Ioannis P. Papanastasiou

Associate Professor

National and Kapodistrian University of Athens

Greece

Research Interests

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Ioannis P. Papanastasiou is an Associate Professor at the National and Kapodistrian University of Athens, Greece. His research areas include the development of novel derivatives aimed at combating Trypanosoma brucei and Mycobacterium tuberculosis, as well as the synthesis of compounds targeting the CB1 receptor. He has contributed significantly to the understanding of antiproliferative compounds and their applications in treating various pathogens.

Articles (12)

Year:

2025

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (8)

Marilena Vlachou

National and Kapodistrian University of Athens

GREECE

View details

Martin Taylor

Associate Professor of Molecular Biology

London School of Hygiene & Tropical Medicine

UNITED KINGDOM

View details

Christos Iliopoulos_Tsoutsouvas

Research Assistant Professor

Northeastern University

UNITED STATES

View details

Andrew TSOTINIS

PROFESSOR

National and Kapodistrian University of Athens

GREECE

View details

Santiago Vazquez

Full professor

University of Barcelona

SPAIN

View details

Laura Bohn

Professor and Chair

Scripps Florida

UNITED STATES

View details

Zijun Gao

Northwestern University

UNITED STATES

View details

Fei Tong

Northeastern University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ioannis P. Papanastasiou

Research Interests

Contact this professor

About

Articles (12)

New Trypanosoma brucei acting derivatives incorporating 1-(4-phenyl)adamantane and 1-(4-phenoxyphenyl)adamantane

Overview of Small Molecules as Fluorescent Probes of Mycobacterium tuberculosis

Synthesis and Testing of Analogs of the Tuberculosis Drug Candidate SQ109 against Bacteria and Protozoa: Identification of Lead Compounds against <i>Mycobacterium abscessus</i> and Malaria Parasites

Probing Adamantane Arylhydroxamic Acids against Trypanosoma brucei and Trypanosoma cruzi

Improved cyclobutyl nabilone analogs as potent CB1 receptor agonists

Improved cyclobutyl nabilone analogs as potent CB1 receptor agonists

Mapping the Melatonin Receptor. 8. Selective MT2 Agonists Derived from 5,6-Dihydroindolo[2,1-a]isoquinolines and Related Systems

Biophysical Evaluation and In Vitro Controlled Release of Two Isomeric Adamantane Phenylalkylamines with Antiproliferative/Anticancer and Analgesic Activity

Evidence for spontaneous cannabinoid withdrawal in mice

Biophysical Evaluation and In Vitro Controlled Release of Two Isomeric Adamantane Phenylalkylamines with Antiproliferative/Anticancer and Analgesic Activity

Evidence for spontaneous cannabinoid withdrawal in mice

An Overview on Target-Based Drug Design against Kinetoplastid Protozoan Infections: Human African Trypanosomiasis, Chagas Disease and Leishmaniases

Collaborators (8)

Marilena Vlachou

Martin Taylor

Christos Iliopoulos_Tsoutsouvas

Andrew TSOTINIS

Santiago Vazquez

Laura Bohn

Zijun Gao

Fei Tong

Make your next move.